title: [Spironolactone versus placebo, bisoprolol and doxazosin to determine the optimal treatment for drug-resistant hypertension].
authors.affiliation: Atención Primaria, Centro de Salud Casas Ibáñez, Casas-Ibáñez, Albacete, España; Universidad Católica San Antonio de Murcia, Murcia, España. Electronic address: jadivison@telefonica.net.
authors.forename: J A
authors.initials: JA
authors.lastname: Divisón Garrote
authors.affiliation: Servicio de Cardiología, Hospital La Paz, Madrid, España.
authors.forename: C
authors.initials: C
authors.lastname: Escobar Cervantes
mesh_terms: D000959:Antihypertensive Agents; D017298:Bisoprolol; D017292:Doxazosin; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension; D013148:Spironolactone
chemical_list: D000959:Antihypertensive Agents; D013148:Spironolactone; D017292:Doxazosin; D017298:Bisoprolol